Astaxanthin from Haematococcus pluvialis ameliorates the chemotherapeutic drug (doxorubicin) induced liver injury through the Keap1/Nrf2/HO-1 pathway in mice-Reference-Cited by-同舟云学术

Astaxanthin from Haematococcus pluvialis ameliorates the chemotherapeutic drug (doxorubicin) induced liver injury through the Keap1/Nrf2/HO-1 pathway in mice

Published:2020 Issue:5 Volume:11 Page:4659-4671
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Ma Haotian¹²³⁴,Chen Shuaihang¹²³⁴,Xiong Huaye⁵⁶⁷⁴,Wang Meng¹²³⁴,Hang Wei¹²³⁴,Zhu Xiaoli¹²³⁴,Zheng Yubin⁸⁹¹⁰⁴,Ge Baosheng¹¹¹²¹³⁴,Li Runzhi¹²³⁴,Cui Hongli¹²³⁴¹⁴^ORCID

Affiliation:

1. Institute of Molecular Agriculture and Bioenergy

2. Shanxi Agricultural University

3. Taigu 030801

4. China

5. College of Resources and Environment

6. Southwest University

7. Chongqing 400716

8. Shandong Jinjing Biotechnology Co.

9. Ltd

10. Weifang 261000

11. Center for Bioengineering and Biotechnology

12. China University of Petroleum (East China)

13. Qingdao 266580

14. Institute of Functional Food

Abstract

The aim of this study is to probe a new function of astaxanthin (AST) from Haematococcus pluvialis on chemotherapeutic drug (doxorubicin) induced liver injury in mice.

Funder

National Natural Science Foundation of China

Key Technology Research and Development Program of Shandong

Shanxi Agricultural University

Shanxi Scholarship Council of China

Shanxi Provincial Key Research and Development Project

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2020/FO/C9FO02429H